Interview with Vadim Y Dudkin, PhD
I first became exposed to oligonucleotide delivery while at Merck upon the acquisition of Sirna in 2006. Part of my work at the time involved glyco
OTS2022-09-24T04:59:02+00:00January 4th, 2018|Categories: Featured Members|
I first became exposed to oligonucleotide delivery while at Merck upon the acquisition of Sirna in 2006. Part of my work at the time involved glyco
Oligonucleotide Therapeutics Society
3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110
info@oligotherapeutics.org
© Copyright 2012 – 2024 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing